Received Jul 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y012074 | OT |
PROQUAD was inadvertently administered to a 77-year-old consumer instead of MMR-II; PROQUAD was inadvertently administered to a 77-year-old consumer instead of MMR-II; no additional AE reported; This spontaneous report was received from an other health professional and refers to a 77-year-old patient of unknown gender. Pertinent medical history, concomitant medications and drug reactions/allergies were not reported. On 02-Jul-2025, the patient was inadvertently received measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot #Y012074 has been verified to be valid, and expiration date was established as 05-Jan-2026) (strength, dose, route of administration, anatomical location was not reported) with reconstituted with sterile diluent (MERCK STERILE DILUENT) (strength, dose, route, lot# and expire date was not reported) for prophylaxis instead of Measles, Mumps, and Rubella (Wistar RA 27-3) (M-M-R II) (Wrong product administered, Product administered to patient of inappropriate age). No additional adverse event was reported.
Sterile diluent